Sangrel

Medicinal product

(Invented) name

Sangrel

Active substance (s)

Bortezomibas

Strength

3,5 mg

Pharmaceutical form

milteliai injekciniam tirpalui

Route (s) of administration

leisti į veną, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01XG01, bortezomib

Marketing authorisation holder

UAB Norameda, Lietuva

Date of authorisation

2015-04-30

Date of renewal

2021-02-18

Documents

3718 Sangrel 3;5_milt-in-t_perr2021-02-18.docx

3718_pakuotes lapelis_2021-02-18.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Kiekviename flakone yra	1 vnt.
Bortezomibas	3,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
60167	74438	1074438	flakonas	N1		Receptinis	LT/1/15/3718/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2024-05-31	Išregistruotas
2021-02-18	Perregistruotas
2015-04-30	Registruotas